ArticleThe oncologist2019

Immune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging Issue.

Luis E Aguirre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.